A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies

Clinical trial NCT00840190 · COMPLETED

Trial details

NCT number: NCT00840190
Sponsor: Piramal Enterprises Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Hematologic Malignancy

Start date: 2008-12-01
Primary completion: 2011-03-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.